Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders.
Jie-Qiong LiYan-Lin BiXue-Ning ShenHui-Fu WangWei XuChen-Chen TanQiang DongYan-Jiang WangLan TanJin-Tai Yunull nullPublished in: Translational neurodegeneration (2020)
CSF α-synuclein is associated with CSF tau levels and could predict neurodegeneration and clinical progression in non-demented elders. This finding indicates that CSF α-synuclein is a potentially useful early biomarker for AD.
Keyphrases